This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Gorman, M. R.
Right arrow Articles by Corrochano, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Gorman, M. R.
Right arrow Articles by Corrochano, V.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, 03 1995, 227-232, Vol 2, No. 2
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease

MR O'Gorman and V Corrochano
Department of Pediatrics, Northwestern University, Children's Memorial Hospital, Chicago, Illinois 60614.

Chronic granulomatous disease (CGD) is characterized by defective killing of intracellular microorganisms due to mutations in one of the four known components of the NADPH oxidase system. This system is responsible for the generation of superoxide and related antimicrobial oxidants. Diagnosis of CGD requires the demonstration of an abnormal oxidase system in the leukocytes of affected patients. Recently, several flow cytometry-based procedures which measure various reactive oxygen intermediates generated by the NADPH oxidase system have been developed. Most of the procedures developed to date require time- consuming granulocyte isolation, washing, and counting procedures, or they lack sensitivity. We have modified an existing procedure such that cell labelling and stimulation are performed directly in whole blood. Optimization of this procedure and its use in the diagnosis of patients with CGD or X-linked carriers are presented.


This article has been cited by other articles:

  • Spickett, G P (2008). Immune deficiency disorders involving neutrophils. J. Clin. Pathol. 61: 1001-1005 [Abstract] [Full Text]  
  • Morgan, D., Cherny, V. V., Murphy, R., Katz, B. Z., DeCoursey, T. E. (2005). The pH dependence of NADPH oxidase in human eosinophils. J. Physiol. 569: 419-431 [Abstract] [Full Text]  
  • Brickson, S., Ji, L. L., Schell, K., Olabisi, R., St. Pierre Schneider, B., Best, T. M. (2003). M1/70 attenuates blood-borne neutrophil oxidants, activation, and myofiber damage following stretch injury. J. Appl. Physiol. 95: 969-976 [Abstract] [Full Text]  
  • (2003). Pathology Quiz Case 1--Diagnosis. Arch Otolaryngol Head Neck Surg 129: 255-255 [Full Text]  
  • Fazal, N., Al-Ghoul, W. M., Choudhry, M. A., Sayeed, M. M. (2001). PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo. Am. J. Physiol. Cell Physiol. 281: C1310-C1317 [Abstract] [Full Text]